EPHA1 and colorectal cancer: Similarly, other pathways reported to cross-talk with Eph-ephrin signaling such as MAPK [26], gastric [27], colorectal cancer [12, 28] and Ras-related pathways [29] were enriched in ligand-stimulated D762N kinase mutant with reduced compartmentalisation phenotype (Fig. 5A).